Dyne Therapeutics, Inc. (DYN)
19.20
-0.39
(-1.99%)
USD |
NASDAQ |
Dec 30, 16:00
19.56
+0.36
(+1.88%)
After-Hours: 20:00
Dyne Therapeutics EPS Diluted (Quarterly): -0.7619 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Avidity Biosciences, Inc. | -1.265 |
| MannKind Corp. | 0.0256 |
| Sarepta Therapeutics, Inc. | -1.795 |
| Denali Therapeutics, Inc. | -0.736 |
| Kymera Therapeutics, Inc. | -0.9413 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -108.04M |
| Total Expenses (Quarterly) | 108.04M |
| Enterprise Value | 2.071B |
| Earnings Yield | -19.06% |
| Normalized Earnings Yield | -19.06 |